• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同方案动员外周血祖细胞的患者单采产物中集落形成细胞、长期培养起始细胞与CD34+细胞的相关性

Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens.

作者信息

Bender J G, Lum L, Unverzagt K L, Lee W, Van Epps D, George S, Coon J, Ghalie R, McLeod B, Kaizer H

机构信息

Immunotherapy Division, Baxter Healthcare Corporation, Round Lake, IL 60073.

出版信息

Bone Marrow Transplant. 1994 Apr;13(4):479-85.

PMID:7517260
Abstract

Peripheral blood progenitor cell (PBPC) populations used for transplantation were analyzed for the presence of CD34+ cells, colony-forming cells (initial CFC), and long-term culture initiating cells (LTC-IC) cultured on irradiated stroma for 5 weeks. Thirty-eight leukapheresis products were studied from 11 patients with breast cancer, 2 with non-Hodgkin's lymphoma and 1 with ovarian cancer harvested during recovery from either cyclophosphamide (CY) chemotherapy or cyclophosphamide-VP16 with G-CSF (CY-VP-G). CY-VP-G products had a threefold higher median number of mononuclear cells collected, a fivefold higher median concentration of CD34 and LTC-IC and a threefold higher concentration of initial-CFC when compared with CY products. CY-VP-G products had a significantly higher ratio of CFU-GM to BFU-E than the CY-mobilized products. Significant correlations of r = 0.89 and r = 0.68 were observed when comparing CD34 and CFC in products from CY or CY-VP-G patients, respectively. Analysis of the regression lines indicated that slopes of these regression lines were significantly different with a ratio of CD34 to initial CFC of 15:1 in the CY-VP-G products versus 5.2:1 with the CY products. These data indicate a higher cloning efficiency of the CD34+ population in the products from CY-mobilized patients. Significant correlations of r = 0.9 (CY) and r = 0.53 (CY-VP-G) were observed when the initial CD34 concentration and the LTC-IC were compared. Comparison of initial CFC with LTC-IC also showed significant correlations (r = 0.94, CY; r = 0.58, CY-VP-G) in samples from both patient groups.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对用于移植的外周血祖细胞(PBPC)群体进行分析,检测其中CD34+细胞、集落形成细胞(初始CFC)以及在经辐照的基质上培养5周的长期培养起始细胞(LTC-IC)的存在情况。研究了11例乳腺癌患者、2例非霍奇金淋巴瘤患者和1例卵巢癌患者的38份白细胞分离产物,这些患者均在接受环磷酰胺(CY)化疗或环磷酰胺-VP16联合G-CSF(CY-VP-G)治疗后恢复期间采集样本。与CY产物相比,CY-VP-G产物采集的单个核细胞中位数数量高出三倍,CD34和LTC-IC的中位数浓度高出五倍,初始CFC浓度高出三倍。CY-VP-G产物中CFU-GM与BFU-E的比例显著高于CY动员的产物。分别比较CY或CY-VP-G患者产物中的CD34和CFC时,观察到显著相关性,r值分别为0.89和0.68。回归线分析表明,这些回归线的斜率存在显著差异,CY-VP-G产物中CD34与初始CFC的比例为15:1,而CY产物为5.2:1。这些数据表明,CY动员患者产物中CD34+群体的克隆效率更高。比较初始CD34浓度和LTC-IC时,观察到显著相关性,CY组r值为0.9,CY-VP-G组r值为0.53。比较两个患者组样本中的初始CFC与LTC-IC时也显示出显著相关性(CY组r = 0.94;CY-VP-G组r = 0.58)。(摘要截选至250字)

相似文献

1
Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens.不同方案动员外周血祖细胞的患者单采产物中集落形成细胞、长期培养起始细胞与CD34+细胞的相关性
Bone Marrow Transplant. 1994 Apr;13(4):479-85.
2
CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.由环磷酰胺和粒细胞集落刺激因子(G-CSF)动员的CD34+细胞在功能上不同于由G-CSF动员的CD34+细胞。
Bone Marrow Transplant. 1998 Mar;21(6):561-8. doi: 10.1038/sj.bmt.1701133.
3
Clonogenic potential and phenotypic analysis of CD34+ cells mobilized by different chemotherapy regimens.不同化疗方案动员的CD34+细胞的克隆形成潜力及表型分析
Haematologica. 1999 Sep;84(9):771-8.
4
Primitive hematopoietic progenitor cells are present in peripheral blood autografts.原始造血祖细胞存在于外周血自体移植物中。
Blood Cells. 1994;20(2-3):351-62; discussion 362-3.
5
Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.从人骨髓、外周血和脐带血中获取、鉴定及培养CD34+细胞。
Blood Cells. 1994;20(2-3):411-23.
6
In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.在非霍奇金淋巴瘤患者的白细胞分离产品中,未成熟造血祖细胞表现出更高的CD90和CD34抗原表达。
Transfus Apher Sci. 2007 Oct;37(2):145-56. doi: 10.1016/j.transci.2007.05.001. Epub 2007 Nov 5.
7
Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection.通过化疗和粒细胞集落刺激因子(G-CSF)联合动员乳腺癌患者外周血祖细胞(PBPC)以及未处理全血采集的可能性。
Bone Marrow Transplant. 1998 Jan;21(2):123-6. doi: 10.1038/sj.bmt.1701058.
8
Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts.外周血自体移植物中原始造血祖细胞的特征分析与定量研究
Exp Hematol. 1994 Sep;22(10):1016-24.
9
Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.采用化疗加重组人粒细胞集落刺激因子动员的血液干细胞进行清髓性预处理治疗后成功进行自体移植。
Exp Hematol. 1993 Apr;21(4):508-14.
10
Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.癌症患者外周血祖细胞采集:影响采集量的因素分析
Haematologica. 1999 Apr;84(4):342-9.

引用本文的文献

1
Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients.慢病毒介导的范可尼贫血患者造血和间充质祖细胞的基因校正。
Mol Ther. 2009 Jun;17(6):1083-92. doi: 10.1038/mt.2009.26. Epub 2009 Mar 10.
2
Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity.用于评估非致癌性血液毒性的替代测试系统。
Environ Health Perspect. 1998 Apr;106 Suppl 2(Suppl 2):541-57. doi: 10.1289/ehp.98106541.
3
An update on peripheral blood progenitor cell transplantation.
外周血祖细胞移植的最新进展。
Ann Hematol. 1995 Jul;71(1):29-33. doi: 10.1007/BF01696229.